PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
16931637-6	2006	Among patients exposed to CO for over 3 h, flow cytometry scans of neutrophils revealed increased surface expression of CD18 and, in some groups, MPO on the cell surface.	Carbon Monoxide	26-28	myeloperoxidase	Homo sapiens	146-149	
27567420-0	2016	Pentraxin 3, ischemia-modified albumin, and myeloperoxidase in predicting a cardiac damage in acute carbon monoxide poisoning.	Carbon Monoxide	100-115	myeloperoxidase	Homo sapiens	44-59	
20146436-2	2010	UV/visible spectroscopy was used to confirm that CO induces small spectral shifts in ferrous MPO, and Fourier transform infrared difference spectroscopy showed definitively that these arose from formation of a heme ferrous-CO compound.	Carbon Monoxide	49-51	myeloperoxidase	Homo sapiens	93-96	
20146436-5	2010	This affinity of MPO for CO is 10 times weaker than its affinity for O(2).	Carbon Monoxide	25-27	myeloperoxidase	Homo sapiens	17-20	
19625608-3	2009	Treatment of human endothelial cells with the myeloperoxidase product HOCl stimulated a concentration- and time-dependent increase in HO-1 protein that resulted in a significant rise in carbon monoxide (CO) production.	Carbon Monoxide	203-205	myeloperoxidase	Homo sapiens	46-61	
10853859-9	2000	Smokers with a low (<75% of the predicted value) diffusing capacity of the lung for carbon monoxide had higher PMNL MPO levels than smokers with a diffusing capacity of >75% pred (p<0.05).	Carbon Monoxide	87-102	myeloperoxidase	Homo sapiens	119-122	
24583458-0	2014	Carbon monoxide-releasing molecule 3 inhibits myeloperoxidase (MPO) and protects against MPO-induced vascular endothelial cell activation/dysfunction.	Carbon Monoxide	0-15	myeloperoxidase	Homo sapiens	46-61	
24583458-0	2014	Carbon monoxide-releasing molecule 3 inhibits myeloperoxidase (MPO) and protects against MPO-induced vascular endothelial cell activation/dysfunction.	Carbon Monoxide	0-15	myeloperoxidase	Homo sapiens	63-66	
24583458-0	2014	Carbon monoxide-releasing molecule 3 inhibits myeloperoxidase (MPO) and protects against MPO-induced vascular endothelial cell activation/dysfunction.	Carbon Monoxide	0-15	myeloperoxidase	Homo sapiens	89-92	
19625608-3	2009	Treatment of human endothelial cells with the myeloperoxidase product HOCl stimulated a concentration- and time-dependent increase in HO-1 protein that resulted in a significant rise in carbon monoxide (CO) production.	Carbon Monoxide	186-201	myeloperoxidase	Homo sapiens	46-61